The pathogenesis of hyperlipidemic acute pancreatitis caused by pancreatic duct hypertension

Jiachen FENG; Ping ZHANG

doi:10.12449/JCH240134

Volume 40 Issue 1

Jan. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(1): 204-207

PDF( 671 KB)

The pathogenesis of hyperlipidemic acute pancreatitis caused by pancreatic duct hypertension

DOI: 10.12449/JCH240134

Jiachen FENG,
Ping ZHANG^{,
,}

First Department of Hepatopancreatobiliary Surgery，Center of General Surgery，The First Hospital of Jilin University，Changchun 130021，China

More Information

Corresponding author: ZHANG Ping， z_ping@jlu.edu.cn （ORCID： 0000-0003-4944-2937）
Received Date: 2023-09-27
Accepted Date: 2023-11-24
Published Date: 2024-01-23

Abstract

Abstract

Compared with acute pancreatitis caused by other factors， hyperlipidemic acute pancreatitis often has a higher rate of severe conditions， greater difficulties in predicting prognosis， and a more complex and unclear pathogenesis. At present， the pathogenesis of hyperlipidemic acute pancreatitis may be associated with the elevation of serum free fatty acids， but the lipid-lowering treatment regimens do not reduce the incidence rate of this disease. Recent studies have further confirmed that pancreatic duct hypertension is an important pathogenesis of acute pancreatitis. The latest research advances have shown that hyperlipidemia can lead to pancreatic duct obstruction by causing pancreatic duct hyperplasia， forming protein embolism at the biliary-pancreatic junction， and damaging the secretory function of the pancreatic duct， while pancreatic duct obstruction can in turn cause pancreatic duct obstruction. This article reviews the latest research advances in hyperlipidemia in causing pancreatic duct obstruction and emphasizes that pancreatic duct hypertension is one of the important pathogeneses of hyperlipidemic acute pancreatitis， which will provide new ideas for exploring the pathogenesis of hyperlipidemic acute pancreatitis.
- Pancreatitis,
- Pancreatic duct hypertension,
- Hyperlipidemias

FullText(HTML)

References(30)

References

[1]	BOXHOORN L, VOERMANS RP, BOUWENSE SA, et al. Acute pancreatitis[J]. Lancet, 2020, 396( 10252): 726- 734. DOI: 10.1016/S0140-6736(20)31310-6.
[2]	GARG PK, SINGH VP. Organ failure due to systemic injury in acute pancreatitis[J]. Gastroenterology, 2019, 156( 7): 2008- 2023. DOI: 10.1053/j.gastro.2018.12.041.
[3]	JOHNSON CD, BESSELINK MG, CARTER R. Acute pancreatitis[J]. BMJ, 2014, 349: g4859. DOI: 10.1136/bmj.g4859.
[4]	SU W, GUO F. Triglyceride-controlling during acute phase of hypertriglyceridemia induced pancreatitis[J]. Chin J Dig Surg, 2023, 22( 1): 89- 93. DOI: 10.3760/cma.j.cn115610-20221220-00755. 苏伟, 郭丰. 高甘油三酯血症性胰腺炎急性期的血脂控制[J]. 中华消化外科杂志, 2023, 22( 1): 89- 93. DOI: 10.3760/cma.j.cn115610-20221220-00755.
[5]	YANG AL, MCNABB-BALTAR J. Hypertriglyceridemia and acute pancreatitis[J]. Pancreatology, 2020, 20( 5): 795- 800. DOI: 10.1016/j.pan.2020.06.005.
[6]	LI Q, HOU CQ, PENG YP, et al. Diabetes and younger age are vital and independent risk factors for acute pancreatitis in patients with severe hypertriglyceridemia[J]. Biomed Res Int, 2019, 2019: 2620750. DOI: 10.1155/2019/2620750.
[7]	JIN M, BAI XY, CHEN XF, et al. A 16-year trend of etiology in acute pancreatitis: The increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis[J]. J Clin Lipidol, 2019, 13( 6): 947- 953. e 1. DOI: 10.1016/j.jacl.2019.09.005.
[8]	ZAFRIR B, SALIBA W, JUBRAN A, et al. Severe hypertriglyceridemia-related pancreatitis: Characteristics and predictors of recurrence[J]. Pancreas, 2019, 48( 2): 182- 186. DOI: 10.1097/MPA.0000000000001235.
[9]	JIN Q, YANG J, MA HL, et al. Value of different scoring systems in predicting the severity and prognosis of hyperlipidemic acute pancreatitis[J]. J Clin Hepatol, 2022, 38( 11): 2551- 2557. DOI: 10.3969/j.issn.1001-5256.2022.11.022. 金秋, 杨婧, 马红琳, 等. 不同评分系统预测高脂血症性急性胰腺炎严重程度及预后的价值分析[J]. 临床肝胆病杂志, 2022, 38( 11): 2551- 2557. DOI: 10.3969/j.issn.1001-5256.2022.11.022.
[10]	GUBENSEK J, BUTUROVIC-PONIKVAR J, ROMOZI K, et al. Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange: An observational cohort study[J]. PLoS One, 2014, 9( 7): e102748. DOI: 10.1371/journal.pone.0102748.
[11]	VALDIVIELSO P, RAMÍREZ-BUENO A, EWALD N. Current knowledge of hypertriglyceridemic pancreatitis[J]. Eur J Intern Med, 2014, 25( 8): 689- 694. DOI: 10.1016/j.ejim.2014.08.008.
[12]	KISS L, FŰR G, PISIPATI S, et al. Mechanisms linking hypertriglyceridemia to acute pancreatitis[J]. Acta Physiol, 2023, 237( 3): e13916. DOI: 10.1111/apha.13916.
[13]	WANG B, XU XB, JIN XX, et al. Effects of ω-3 fatty acids on toll-like receptor 4 and nuclear factor κB p56 in the pancreas of rats with severe acute pancreatitis[J]. Pancreas, 2017, 46( 10): 1267- 1274. DOI: 10.1097/MPA.0000000000000935.
[14]	SU YR, HONG YP, MEI FC, et al. High-fat diet aggravates the intestinal barrier injury via TLR4-RIP3 pathway in a rat model of severe acute pancreatitis[J]. Mediators Inflamm, 2019, 2019: 2512687. DOI: 10.1155/2019/2512687.
[15]	SIMHA V. Management of hypertriglyceridemia[J]. BMJ, 2020: m3109. DOI: 10.1136/bmj.m3109.
[16]	HARVEY MH, WEDGWOOD KR, AUSTIN JA, et al. Pancreatic duct pressure, duct permeability and acute pancreatitis[J]. Br J Surg, 1989, 76( 8): 859- 862. DOI: 10.1002/bjs.1800760832.
[17]	LERCH MM, SALUJA AK, RÜNZI M, et al. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum[J]. Gastroenterology, 1993, 104( 3): 853- 861. DOI: 10.1016/0016-5085(93)91022-a.
[18]	ROMAC JM, SHAHID RA, SWAIN SM, et al. Piezo1 is a mechanically activated ion channel and mediates pressure induced pancreatitis[J]. Nat Commun, 2018, 9( 1): 1715. DOI: 10.1038/s41467-018-04194-9.
[19]	SWAIN SM, ROMAC JM, SHAHID RA, et al. TRPV4 channel opening mediates pressure-induced pancreatitis initiated by Piezo1 activation[J]. J Clin Invest, 2020, 130( 5): 2527- 2541. DOI: 10.1172/JCI134111.
[20]	WEN L, JAVED TA, YIMLAMAI D, et al. Transient high pressure in pancreatic ducts promotes inflammation and alters tight junctions via calcineurin signaling in mice[J]. Gastroenterology, 2018, 155( 4): 1250- 1263.e5. DOI: 10.1053/j.gastro.2018.06.036.
[21]	LERCH MM, AGHDASSI AA, SENDLER M. Cell signaling of pancreatic duct pressure and its role in the onset of pancreatitis[J]. Gastroenterology, 2020, 159( 3): 827- 831. DOI: 10.1053/j.gastro.2020.07.027.
[22]	NORDSTOGA K, SØRBY R, OLIVECRONA G, et al. Pancreatitis in hyperlipemic mink(Mustela vison)[J]. Vet Pathol, 2012, 49( 3): 557- 561. DOI: 10.1177/0300985811417248.
[23]	KANEKO K, ANDO H, SEO T, et al. Proteomic analysis of protein plugs: Causative agent of symptoms in patients with choledochal cyst[J]. Dig Dis Sci, 2007, 52( 8): 1979- 1986. DOI: 10.1007/s10620-006-9398-4.
[24]	KAMISAWA T, KANEKO K, ITOI T, et al. Pancreaticobiliary maljunction and congenital biliary dilatation[J]. Lancet Gastroenterol Hepatol, 2017, 2( 8): 610- 618. DOI: 10.1016/S2468-1253(17)30002-X.
[25]	ZHAO CS, YAO WJ, WANG ZZ, et al. Efficacy of pancreatic duct stenting in treatment of hypertriglyceridemic pancreatitis: A report of 33 cases[J]. Chin J Gen Surg, 2021, 30( 9): 1023- 1030. DOI: 10.7659/j.issn.1005-6947.2021.09.005. 赵成思, 姚维杰, 王佐正, 等. 胰管支架治疗高三酰甘油血症性胰腺炎的疗效: 附33例报告[J]. 中国普通外科杂志, 2021, 30( 9): 1023- 1030. DOI: 10.7659/j.issn.1005-6947.2021.09.005.
[26]	WANG J, YANG CX. Discussion on the occurrence, prevention and treatment of biliary pancreatitis via analyzing the anatomy of choledocho-pancreatico-duodenal junction[J]. Chin J Pract Surg, 2020, 40( 11): 1263- 1265. DOI: 10.19538/j.cjps.issn1005-2208.2020.11.09. 王坚, 杨传鑫. 从胆胰肠结合部解剖谈胆源性胰腺炎发生与防治[J]. 中国实用外科杂志, 2020, 40( 11): 1263- 1265. DOI: 10.19538/j.cjps.issn1005-2208.2020.11.09.
[27]	LEE MG, MUALLEM S. Pancreatitis: The neglected duct[J]. Gut, 2008, 57( 8): 1037- 1039. DOI: 10.1136/gut.2008.150961.
[28]	MORAN O. The gating of the CFTR channel[J]. Cell Mol Life Sci, 2017, 74( 1): 85- 92. DOI: 10.1007/s00018-016-2390-z.
[29]	MALÉTH J, BALÁZS A, PALLAGI P, et al. Alcohol disrupts levels and function of the cystic fibrosis transmembrane conductance regulator to promote development of pancreatitis[J]. Gastroenterology, 2015, 148( 2): 427- 439.e16. DOI: 10.1053/j.gastro.2014.11.002.
[30]	LARUSCH J, JUNG J, GENERAL IJ, et al. Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis[J]. PLoS Genet, 2014, 10( 7): e1004376. DOI: 10.1371/journal.pgen.1004376.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(4)

Get Citation

PDF

XML

Article Metrics

Article views (353) PDF downloads(46)

The pathogenesis of hyperlipidemic acute pancreatitis caused by pancreatic duct hypertension

DOI: 10.12449/JCH240134

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

The pathogenesis of hyperlipidemic acute pancreatitis caused by pancreatic duct hypertension

DOI: 10.12449/JCH240134

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content